Form 4: Iradimed Corp Executive Receives Stock Grants Under Equity Incentive Plans
Stock Grant Disclosure
Iradimed Corp's executive, Monty K. Allen, received grants of common stock and restricted stock units under the company's 2014 and 2023 Equity Incentive Plans.
Summary
- Monty K. Allen, an executive at Iradimed Corp, received common stock and restricted stock units.
- The grants were made under the company's 2014 and 2023 Equity Incentive Plans.
- On December 7, 2022, Allen received restricted stock units that vest in two equal annual installments starting December 7, 2023.
- On December 7, 2023, Allen received additional restricted stock units that vest in two equal annual installments starting December 7, 2024.
- Upon vesting, each restricted stock unit converts into one share of common stock.
Sentiment
Score: 7
Explanation: The document reflects standard corporate practice for executive compensation, which is generally viewed positively as it aligns executive interests with shareholder value. There are no negative implications.
Positives
- The grants of stock and restricted stock units align executive interests with shareholder value.
- The vesting schedule encourages long-term commitment from the executive.
Industry Context
Stock grants and equity incentive plans are common practices in the corporate world to attract, retain, and motivate key executives.
Comparison to Industry Standards
- Many companies in the medical device industry use equity-based compensation to align executive interests with shareholder value.
- The vesting schedules described are typical for restricted stock unit grants, often spanning multiple years to encourage long-term performance.
Stakeholder Impact
- Shareholders may view the stock grants positively as they align executive interests with company performance.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 2022-12-07 | Monty K. Allen received restricted stock units under the 2014 Equity Incentive Plan. |
| 2023-12-07 | First vesting date for the 2022 restricted stock units and Monty K. Allen received restricted stock units under the 2023 Equity Incentive Plan. |
| 2024-12-07 | Second vesting date for the 2022 restricted stock units and first vesting date for the 2023 restricted stock units. |
| 2024-12-10 | Date of filing of the document. |
Keywords
Equity Incentive Plan, Restricted Stock Units, Common Stock, Stock Grants, Vesting, Executive Compensation, Iradimed Corp
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.